UC San Diego, Moores Cancer Center

San Diego, California 92093-0698

4 studies enrolling now · 19 studies all time

What they study most

Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Adenovirus, Advanced Solid Tumor, Advanced Solid Tumors, Advanced Tumors, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Brain Tumor, Recurrent, Breast Cancer

Studies at this site

• A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer — Recruiting now
• A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis — Recruiting now
• Loncastuximab Tesirine and Rituximab Followed by DA-EPOCH-R for Treating Patients With High-Risk Diffuse Large B-cell Lymphoma — Recruiting now
• Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms — Recruiting now
• A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma — Running, not enrolling
• Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS — Completed
• A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer — Stopped early
• Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT) — Running, not enrolling
• A Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation — Stopped early
• Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study — Withdrawn before enrolling
• A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) — Completed
• A Study of PY314 in Subjects With Advanced Solid Tumors — Stopped early
• Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile — Completed
• A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor — Paused
• Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease — NO_LONGER_AVAILABLE
• Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF — Completed
• Trial of AB-205 in Adults With Lymphoma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation — Completed
• Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers — Stopped early
• Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor — Completed